Denali Therapeutics Inc. (DNLI) - Dilution Analysis

Visualizing historical and potential share dilution over time

View Stock Details

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Dilution Analysis

Medium Risk

Moderate dilution risk

Last updated: May 07, 2026

Risk Assessment Details

Potential Dilution: 0.0% of current shares

Recent Dilution: 10.64% (2 years)

Historical Dilution Factor: moderate recent dilution

Outstanding Shares

160M

Potential Supply

Additional shares possible

Splits

None

Past 2 years

Summary

DNLI currently has 159M outstanding shares. with minimal authorized share overhang for future dilution. The company has diluted shareholders by 10.64% over the past 2 years through share issuances.

Share Structure Timeline

Outstanding Shares

Total Supply

Historical Data Points

Date	Event	Outstanding
May 07, 2026	10-Q filing \| 158.7M shares outstanding	160M
Nov 06, 2025	10-Q filing \| 146.7M shares outstanding	150M
Aug 11, 2025	10-Q filing \| 146.2M shares outstanding	150M
May 06, 2025	10-Q filing \| 145.3M shares outstanding	150M
Feb 27, 2025	10-K filing \| 145.2M shares outstanding	150M
Nov 06, 2024	10-Q filing \| 143.9M shares outstanding	140M
Aug 01, 2024	10-Q filing \| 143.2M shares outstanding	140M
May 07, 2024	10-Q filing \| 149.4M shares outstanding	150M
Feb 28, 2024	10-K filing \| 137.4M shares outstanding	140M
Nov 07, 2023	10-Q filing \| 137.6M shares outstanding	140M
Aug 08, 2023	10-Q filing \| 137.0M shares outstanding	140M
May 08, 2023	10-Q filing \| 136.5M shares outstanding	140M
Feb 27, 2023	10-K filing \| 125.5M shares outstanding	130M
Nov 03, 2022	10-Q filing \| 123.5M shares outstanding	120M
Aug 08, 2022	10-Q filing \| 123.0M shares outstanding	120M
May 05, 2022	10-Q filing \| 122.7M shares outstanding	120M
Feb 28, 2022	10-K filing \| 121.5M shares outstanding	120M
Nov 04, 2021	10-Q filing \| 121.7M shares outstanding	120M
Aug 04, 2021	10-Q filing \| 121.3M shares outstanding	120M
May 05, 2021	10-Q filing \| 120.9M shares outstanding	120M
Feb 26, 2021	10-K filing \| 112.7M shares outstanding	110M
Nov 05, 2020	10-Q filing \| 119.9M shares outstanding	120M
Aug 07, 2020	10-Q filing \| 106.0M shares outstanding	110M
May 07, 2020	10-Q filing \| 105.6M shares outstanding	110M
Feb 27, 2020	10-K filing \| 97.7M shares outstanding	98M

Back to DNLI Details